US equities
|
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
TSLA
$407.46
▲+4.04%
NVDA
$217.94
▲+0.90%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
TSLA
$407.46
▲+4.04%
NVDA
$217.94
▲+0.90%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
11.23
+1.32 (+13.32%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
July 06, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021
↗
July 02, 2021
Upgrades According to Deutsche Bank, the prior rating for Encompass Health Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 02, 2021
Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5...
Via
Benzinga
Return On Capital Employed Overview: Arcturus Therapeutics
↗
June 24, 2021
During Q1, Arcturus Therapeutics's (NASDAQ:ARCT) reported sales totaled $2.13 million. Despite a 85.53% in earnings, the company posted a loss of $57.67 million. In Q4, Arcturus...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021
↗
June 21, 2021
Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 21, 2021
Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...
Via
Benzinga
10 Biggest Price Target Changes For Monday
↗
June 21, 2021
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...
Via
Benzinga
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
June 09, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Looking Into Arcturus Therapeutics's Return On Capital Employed
↗
June 08, 2021
In Q1, Arcturus Therapeutics (NASDAQ:ARCT) posted sales of $2.13 million. Earnings were up 85.53%, but Arcturus Therapeutics still reported an overall loss of $57.67 million....
Via
Benzinga
High Flyers At Much Lower Altitudes
↗
May 14, 2021
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd.
Via
Talk Markets
Arcturus Therapeutics: Q1 Earnings Insights
↗
May 10, 2021
Shares of Arcturus Therapeutics (NASDAQ:ARCT) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 220.90% over...
Via
Benzinga
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
May 10, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
↗
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
↗
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
↗
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
↗
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
Arcturus Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 10, 2021
May 03, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
